Thus, the urgent need for pharmacological treatments against P-gp-overexpressing-resistant cancer can be effectively addressed if novel mechanisms of approved anticancer drugs are identified, given that these drugs can be used without further toxicity assessments [21,22,23]. Here, PGP is linked to cancer.